| Dr Gregory Michael Cowan, MD | |
|
9145 W Thunderbird Rd Ste 101, Peoria, AZ 85381-4820 | |
| (623) 815-7800 | |
| (623) 815-7900 |
| Full Name | Dr Gregory Michael Cowan |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 16 Years |
| Location | 9145 W Thunderbird Rd Ste 101, Peoria, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164756904 | NPI | - | NPPES |
| 003990800 | Medicaid | FL | |
| 935585 | Medicaid | AZ |
| Entity Name | Phoenix Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316952971 PECOS PAC ID: 2769396589 Enrollment ID: O20031117000388 |
News Archive
A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth.
Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
› Verified 7 days ago
| Entity Name | North Scottsdale Allergy Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588192397 PECOS PAC ID: 5294082954 Enrollment ID: O20180726000729 |
News Archive
A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth.
Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
› Verified 7 days ago
| Entity Name | Livwell Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811527732 PECOS PAC ID: 1052738440 Enrollment ID: O20200831002515 |
News Archive
A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth.
Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Michael Cowan, MD 9145 W Thunderbird Rd Ste 101, Peoria, AZ 85381-4820 Ph: (623) 815-7800 | Dr Gregory Michael Cowan, MD 9145 W Thunderbird Rd Ste 101, Peoria, AZ 85381-4820 Ph: (623) 815-7800 |
News Archive
A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth.
Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
› Verified 7 days ago
Kevin M Boesel, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13965 N. 75th Avenue, Peoria, AZ 85381 Phone: 602-843-2991 Fax: 602-978-1226 | |
Mr. Peter M Freedman, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 11361 N 99th Ave, Ste 201, Peoria, AZ 85345 Phone: 623-974-4800 Fax: 623-974-0018 | |
Dr. Levente Edward Erdos, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13965 N. 75th Avenue, Peoria, AZ 85381 Phone: 602-843-2991 Fax: 602-978-1226 | |
Ronald K Jorgensen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13965 N. 75th Avenue, Peoria, AZ 85381 Phone: 602-843-2991 Fax: 602-978-1226 | |
Mark Everett Rose, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13965 N 75th Ave, Peoria, AZ 85381 Phone: 602-843-2991 Fax: 602-978-1226 |